HUSA, Petr and Petr HUSA. Diabetes mellitus a hepatitida C (Diabetes mellitus and hepatitis C). Forum diabetologicum. Brno: Facta Medica, 2016, vol. 5, No 3, p. 134-136. ISSN 1805-3807.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Diabetes mellitus a hepatitida C
Name (in English) Diabetes mellitus and hepatitis C
Authors HUSA, Petr (203 Czech Republic, belonging to the institution) and Petr HUSA (203 Czech Republic, guarantor, belonging to the institution).
Edition Forum diabetologicum, Brno, Facta Medica, 2016, 1805-3807.
Other information
Original language Czech
Type of outcome Article in a journal
Field of Study 30300 3.3 Health sciences
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/16:00092645
Organization unit Faculty of Medicine
Keywords (in Czech) extrahepatální manifestace; chronická hepatitida C; přímo působící virostatika
Keywords in English extrahepatic manifestations; chronic hepatitis C; direct acting antivirals
Tags EL OK
Tags Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 4/1/2017 16:32.
Abstract
Extrahepatální projevy infekce virem hepatitidy C (HCV) jsou velmi časté. Souvislost s infekcí HCV je považována za prokázanou i u membranoproliferativní glomerulonefritidy, leukocytoklastické vaskulitidy, lymfoproliferativ-ních onemocnění (zejména B-buněčného lymfomu), Sjógrenova a sicca syndromu, lichen planus, porfyria cuta-nea tarda a diabetes mellitus. Antivirová terapie chronické infekce HCV může zabránit progresi do diabetů u pacientů s prediabetem a redukovat nebezpečí vzniku renálních a kardiovaskulárních komplikací u pacientů s již vyvinutým diabetem.
Abstract (in English)
Extrahepatic manifestations of hepatitis C virus infection (HCV) are very common. A link with the HCV infection is considered to be established with membranoproliferative glomerulonephritis, leukocytoclastic vasculitis, lympho-proliferative disorders (in particular B-cell lymphoma), Sjogren and sicca syndrome, lichen planus, porfyria cuta-nea tarda and diabetes mellitus. Antiviral therapy may prevent progression to diabetes in patients with prediabe-tes who have hepatitis C and may reduce renal and cardiovascular complications in patients with established diabetes who have hepatitis C.
PrintDisplayed: 25/5/2024 21:49